|1.||Shaaban, Abeer M: 1 article (01/2013)|
|2.||Turton, E P L: 1 article (01/2013)|
|3.||Merchant, William: 1 article (01/2013)|
|4.||Toyokuni, T: 1 article (01/2001)|
|5.||Phelps, M E: 1 article (01/2001)|
|6.||Bauer, E: 1 article (01/2001)|
|7.||Barrio, J R: 1 article (01/2001)|
|8.||Gambhir, S S: 1 article (01/2001)|
|9.||Herschman, H R: 1 article (01/2001)|
|10.||Nguyen, K: 1 article (01/2001)|
|1.||Pituitary Neoplasms (Pituitary Adenoma)
09/01/1997 - "The aim of this study was to define whether assessment of the uptake of [18F]fluoro-ethyl-spiperone (FESP) with positron emission tomography (PET) could be helpful for the differential diagnosis of pituitary adenomas and other parasellar lesions, and for establishing the appropriate therapeutic approach. "
01/01/2001 - "In mice carrying tumors expressing either HSV1-tk or D2R reporter genes, there is a corresponding retention of FPCV and FESP, respectively. "
05/01/1999 - "Tumors expressing the transfected D2R reporter gene retain substantially more FESP than control tumors. "
01/01/2001 - "Two mice carrying tumors expressing two different reporter genes, HSV1-tk and dopamine type 2 receptor (D2R), were also imaged by microPET using FPCV (day 1) and 3-(2'-[18F]fluoroethyl)spiperone (FESP) (day 2). "